Head-to-head
ET Money vs Zerodha Coin
Direct MFs with expense analytics Zerodha Coin: Direct mutual funds inside Zerodha
4.3/ 5 | 4.4/ 5 | |
|---|---|---|
| Best for | Data-driven MF investors who want analytics over execution. | Existing Zerodha users investing in direct mutual funds. |
| Portfolio health check | ✓ Fund report cardsconfirming | — |
| Direct MF plans | ✓ All AMCs + analyticssource | ✓ All AMCs, zero commissionsource |
| SIP / STP / SWP | — | ✓ SIP supported in demat formconfirming |
| Mutual funds | ✓ Supported | ✓ Supported |
| IPO | — | — |
| US stocks | — | — |
| Fees & pricing score | 4.6/5 | 4.8/5 |
| Trading platforms score | 4.4/5 | 4.2/5 |
| Customer support score | 3.9/5 | 3.9/5 |
| Research & education score | 4.2/5 | 3.0/5 |
| Ease of opening score | 4.5/5 | 4.3/5 |
Highlighted rows differ. “Confirming” means we haven't re-verified that figure yet — check the official pricing page.
Used one of these? Tell the next investor in 30 seconds.
A star rating and one detail is enough. Human-moderated, no account needed.
4.4/ 5
The natural MF home for Zerodha users. Standalone seekers may prefer Kuvera or ET Money.
ET Money: strengths & weaknesses
What we like
- Best-in-class portfolio analytics
- Direct plans with tracking tools
- Expense-manager integration
Watch out for
- Upsells paid Genius packs
- Insurance cross-sell noise
- Stocks not supported
Zerodha Coin: strengths & weaknesses
What we like
- True direct plans, zero commission
- Deep AMC coverage
- Seamless with a Zerodha demat account
Watch out for
- Requires a Zerodha account
- Demat-form units (not for everyone)
- Analytics weaker than ET Money/Kuvera
Affiliate disclosure: LetsInvest earns a commission if you open an account via links on this page — at no extra cost to you. Rankings are editorial and never sold. Read how we make money and our methodology.
How we research. Every fee on this site carries a source and a verification date. Data is re-checked against official broker pages; read our editorial methodology. LetsInvest is a research publication, not a financial adviser — see our terms.